A recently released Avalere analysis shows the majority of health plans are interested in forming outcomes-based contracts with biopharmaceutical manufacturers, tying product reimbursement to patient outcomes. Which drugs will be targeted first? See more here. (Source: Rujul Desai, Avalere, 6/16/16)
You are here: / / Which Therapeutic Areas are Targets for Outcomes-Based Contracts?